Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Maria Q. B. Petzel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7982-8828; OpenAlex author ID A5011154892, A5138962000. Sources: OpenAlex.

Their work

Papers
18 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
82
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 3 papers · 2018: 1 paper · 2019: 4 papers · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 3 papers

Papers 18

  1. Pancreatic Enzyme Replacement Therapy (PERT) in Pancreatic Cancer: First U.S. Consensus Highlights on Dosing, Management, and Provider Inertia. Co-author DOI 10.1093/oncolo/oyag389↗
  2. Aerobic Exercise Activates S1PR1 Signaling in Tumor Endothelial Cells to Promote Vascular Function in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-4733↗
  3. Exercise Modulates Microbial Metabolites and Induces Stromal Remodeling in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-5143↗
  4. Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jamasurg.2024.5191↗
  5. Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Ran… Co-author DOI 10.1097/sla.0000000000005878↗
  6. Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer. Co-author DOI 10.1016/j.ccell.2022.05.006↗
  7. The Role of Home-Based Exercise in Maintaining Skeletal Muscle During Preoperative Pancreatic Cancer Treatment. Co-author DOI 10.1177/1534735420986615↗
  8. Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1177/1756284820964319↗
  9. Association between frailty syndrome and survival in patients with pancreatic adenocarcinoma. Co-author DOI 10.1002/cam4.2157↗
  10. Physical activity and exercise during preoperative pancreatic cancer treatment. Co-author DOI 10.1007/s00520-018-4493-6↗
  11. Supports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods Study. Co-author DOI 10.1123/jpah.2019-0027↗
  12. Home-Based Exercise Prehabilitation During Preoperative Treatment for Pancreatic Cancer Is Associated With Improvement in Physical Function and Quality of Life. Co-author DOI 10.1177/1534735419894061↗
  13. Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy. Co-author DOI 10.1007/s11605-017-3618-4↗
  14. Home-based exercise during preoperative therapy for pancreatic cancer. Co-author DOI 10.1007/s00423-017-1599-0↗
  15. Symptom Management and Palliative Care in Pancreatic Cancer. First author DOI 10.1097/ppo.0000000000000293↗
  16. Nutrition Implications for Long-Term Survivors of Pancreatic Cancer Surgery [Formula: see text]. Co-author DOI 10.1177/0884533617722929↗
  17. Poster 68 Feasibility of a Prehabilitation Program for Patients with Potentially Resectable Pancreatic Cancer: Pilot Study. Co-author DOI 10.1016/j.pmrj.2016.07.111↗
  18. Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. Co-author DOI 10.1245/s10434-014-4285-2↗

Closest collaborators

The 25 strongest of 82 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Matthew H. G. Katz · 14 shared papers, 2015–2026 · strength 1.52
  2. An Ngo‐Huang · 13 shared papers, 2015–2026 · strength 1.37
  3. Nathan H. Parker · 13 shared papers, 2015–2026 · strength 1.37
  4. Keri Schadler · 9 shared papers, 2017–2026 · strength 1.10
  5. David R. Fogelman · 8 shared papers, 2015–2019 · strength 0.57
  6. Jeffrey E. Lee · 7 shared papers, 2015–2023 · strength 0.55
  7. Sumedha Pareek · 3 shared papers, 2022–2026 · strength 0.54
  8. Florencia M. McAllister · 3 shared papers, 2022–2026 · strength 0.54
  9. Laura R. Prakash · 4 shared papers, 2018–2026 · strength 0.53
  10. Karen M. Basen-Engquist · 5 shared papers, 2019–2023 · strength 0.50
  11. Riccardo Ballarò · 2 shared papers, 2026 · strength 0.42
  12. Robin D. Wright · 2 shared papers, 2026 · strength 0.42
  13. Eduardo D Bruera · 4 shared papers, 2017–2023 · strength 0.38
  14. Jason B. Fleming · 5 shared papers, 2015–2019 · strength 0.33
  15. Eugene Jon Koay · 2 shared papers, 2023–2025 · strength 0.29
  16. Ching-Wei David Tzeng · 3 shared papers, 2018–2023 · strength 0.28
  17. Rebecca Munoz · 1 shared paper, 2026 · strength 0.26
  18. Dallas Gallagher · 1 shared paper, 2026 · strength 0.26
  19. Amy Hacker‐Prietz · 1 shared paper, 2026 · strength 0.26
  20. Allison Rosenzweig · 1 shared paper, 2026 · strength 0.26
  21. Jordan M. Cloyd · 2 shared papers, 2018–2025 · strength 0.22
  22. Guanshu Liu · 1 shared paper, 2026 · strength 0.22
  23. Michael P. Kim · 2 shared papers, 2018–2023 · strength 0.20
  24. Vidhi Chandra · 1 shared paper, 2026 · strength 0.20
  25. Nagireddy Putluri · 1 shared paper, 2026 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.